Clinical Chemistry Analyzers Market Size to Reach USD 28.18 Billion By 2033 - BioSpace

According to Nova One Advisor, the global clinicalchemistry analyzers market size was valued at USD 18.73 Billion in 2023and is poised to grow from USD 19.51 Billion in 2024 to USD 28.18 Billion by2033, at a CAGR of 4.17 % during the forecast period (2024-2033)

The Complete Study is Now Available for Immediate Access| Download the Sample Pages of this Report@ https://www.novaoneadvisor.com/report/sample/7123

The major factor driving the market growth is the increasingprevalence of chronic diseases, such as diabetes. This significant growth indisease prevalence has encouraged companies to produce advanced chemistryanalyzers that help in diagnosis.

The clinical chemistry analyzers market deals with medicaldevices used to analyze and measure various substances in bodily fluids such asurine, serum, or blood. It automates quantifying and detecting compounds suchas hormones, enzymes, electrolytes, and glucose, helping manage and diagnosediseases like kidney diseases, liver disorders, and diabetes. The risingtechnological advancements in clinical chemistry products led to specializeddiagnosis and early disease detection in the areas of endocrinology,gynecology, and oncology and allowed testing in a larger quantity. Theseadvancements comprise artificial intelligence, improved pattern recognition,computer-assisted interpretation, advanced modeling & parameter estimation,and better resolution.

In addition, the main advantage of the automated analyzersis that they automatically control data, enabling real-time automation,automatic variable adjustment, and efficient parameter monitoring. These toolsalso facilitate the immediate generation of results and analyze a wide range ofsamples. However, the major challenge for manufacturers, hospitals, andlaboratories is the high investment needed for these tools, which will lead tohigh costs and decreased affordability.

Key Takeaways:

Immediate Delivery is Available | Get Full Report Access@https://www.novaoneadvisor.com/report/checkout/7123

Clinical Chemical Analysers MarketTrends

• The rising geriatric population andlifestyle-related diseases, such as kidney disorders, cardiovascular diseases,diabetes, and hypertension, contribute to market expansion.

• The rising demand for diseasemanagement and diagnostic tools, including various tests like renal and liverpanels, lipid profiles, and basic metabolic panels, is expected to boost themarket growth.

• The rising emphasis on preventivemedicine and ongoing technical advancements that improve accuracy andefficiency are further anticipated to drive the growth of the clinicalchemistry analyzers market.

U.S. Clinical Chemistry Analyzers Market Size, Share and Trends 2024 to 2033

The U.S. clinical chemistry analyzers market size was valuedat USD 8.18 Billion in 2023 and is expected to grow from USD 8.54 Billion in2024 to reach USD 12.58 billion by 2033, at a CAGR of 4.4% during the forecastperiod (2024-2033)

North America led the clinical chemistry analyzers marketwith the largest share in 2023. The regional market growth is driven by theincreasing healthcare expenditure in the region. The well-established and advancedhealthcare infrastructure in the U.S. has led to a high adoption rate forclinical reagents and chemistry in hospitals and laboratories. In addition,favorable healthcare refund policies in this region have also encouragedgreater penetration of automated chemistry analyzers.

U.S. Clinical Chemistry Analyzers Market Trends

The U.S. is leading the market due to the presence of alarge number of market players, continuous technological advancements, and thegrowing usage of analyzers in the healthcare industry. Some of the majorplayers are Siemens AG, Ortho-Clinical Diagnostics, Mindray MedicalInternational Ltd., Johnson & Johnson, Horiba Ltd., Elitech Group, andBeckman Coulter. In July 2023, Siemens Healthineers received FDA clearance forits Atellica CI Analyzer, which is anticipated to drive the market growth. Inaddition, the increasing geriatric population is expected to boost the demand fordiagnostic services and tests, significantly fueling the clinical chemistryanalyzers market growth in the U.S.

Asia Pacific is expected to witness rapid growth in themarket throughout the forecast period. This is due to the presence of leadingclinical chemistry product manufacturers in countries such as China and Indiaand the rising target population. In addition, rising investments in researchand development activities by global players are expected to drive marketgrowth in the region.

China Clinical Chemistry Analyzers Market Trends

• For instance, in July 2024, aclinical diagnostics leader, Beckman Coulter Diagnostics, introduced anintegrated immunoassay analyzer and clinical chemistry, the new DxC 500iClinical Analyzer. As healthcare systems around the world strategically adoptnetworked laboratory operational models for patient access and betterefficiency, Beckman Coulter continues to introduce advanced innovations to meetthe needs of the entire network with specific solutions for independentlaboratories or satellites.

Buy Now Full Report: https://www.novaoneadvisor.com/report/checkout/7123

Top 9 Clinical Chemistry Analyzers forSmall to Mid-Sized Laboratories in 2024

Clinical chemistry analyzers play a crucial role in medicaldiagnostics, allowing laboratories to perform a wide range of tests on patientsamples to diagnose various conditions. With the ever-growing demand foraccurate and rapid results, it's important for small to mid-sized laboratoriesto invest in the best analyzers that can provide fast, reliable, and consistentresults. In this article, we will discuss the top 9 clinical chemistryanalyzers suitable for small to mid-sized laboratories in 2024.

Seamaty SD1 - Seamaty

The Seamaty SD1 is a fullyautomated chemistry analyser designed for on-site testing. It requires only0.1cc of whole blood, serum, or plasma to provide fast, accurate medicaldiagnosis. It utilizes cloud computing to assist operators in making medicaldecisions remotely and includes advanced features such as built-in centrifuge,QR code scanning, and real-time quality control. The test results areautomatically printed after just 12 minutes, making it a great option for smallto mid-sized laboratories looking for a portable and easy-to-use analyser.

Cobas c 701 - Roche

The Cobas c 701 by Roche is ahigh-throughput clinical chemistry analyser that can perform up to 2,000 testsper hour. It requires minimal maintenance and offers advanced features such asautomatic reflex testing, STAT testing, and real-time result monitoring. It's agreat option for laboratories that need to process a large number of samplesquickly. But as a high-end instrument, it can be quite expensive topurchase and maintain.

Cobas c 702 - Roche

The Cobas c 702 by Roche is similar to thec 701, but it offers even higher throughput, with the ability to perform up to3,000 tests per hour. It also includes an automatic sample loader and canperform STAT tests in just 12 minutes, making it an excellent option for busylaboratories that require quick results.

Dimension EXL withLM - Siemens

The Dimension EXL with LM by Siemens is aversatile clinical chemistry analyzer that can perform a wide range of tests onvarious sample types, including serum, plasma, and urine. It can also performspecial chemistries and immunosuppressant drug monitoring. With a throughput ofup to 1,200 tests per hour, it's ideal for small to mid-sized laboratories withdiverse testing needs.

Vitros 5600 - Ortho

Clinical Diagnostics The Vitros 5600 byOrtho Clinical Diagnostics is a compact, high-throughput clinical chemistryanalyzer that can perform up to 1,800 tests per hour. It requires minimalmaintenance and offers a broad menu of tests, including routine chemistries,immunoassays, and infectious disease testing. Its small size makes it a goodoption for laboratories with limited space.

Architect c4000 - Abbott

The Architect c4000 by Abbott is a clinicalchemistry analyzer that can perform up to 800 tests per hour. It offers a widemenu of tests, including routine chemistries, immunoassays, and therapeuticdrug monitoring. It also includes advanced features such as automatic reflextesting and STAT testing. Its compact size and ease of use make it a popularchoice for small to mid-sized laboratories.

Beckman Coulter AU680 - BeckmanCoulter

The Beckman Coulter AU680 is ahigh-throughput clinical chemistry analyzer that can perform up to 1,200 testsper hour. It includes advanced features such as automatic reflex testing andSTAT testing, as well as onboard quality control and calibration. Itsuser-friendly interface and low maintenance requirements make it a good optionfor small to mid-sized laboratories.

Advia 2400 - Siemens

The Advia 2400 by Siemens is a clinicalchemistry analyzer that can perform up to 1,200 tests per hour. It offers abroad menu of tests, including routine chemistries, immunoassays, andtherapeutic drug monitoring. It also includes advanced features such asautomatic reflex testing and STAT testing, making it a great option for busylaboratories.

Olympus AU400e - Olympus

The Olympus AU400e is a reliable clinicalchemistry analyzer that can perform up to 400 tests per hour. It offers a broadmenu of tests, including routine chemistries, immunoassays, and therapeuticdrug monitoring. It also includes onboard quality control and calibration,making it a good option for laboratories with limited resources formaintenance and quality control.

calibration, making it a good option forlaboratories with limited resources for maintenance and quality control.

Analyzer

Manufacturer

Pros

Cons

Seamaty SD1

Seamaty

Maintenance-free, user-friendly, fast results

Limited menu of tests

Cobas c 701

Roche

High throughput, comprehensive menu of tests, user-friendly

Requires regular maintenance, limited flexibility, high cost

Cobas c 702

Roche

Very high throughput, comprehensive menu of tests, user-friendly

Requires regular maintenance, high cost

Dimension EXL with LM

Siemens

Comprehensive menu of tests, user-friendly

Requires regular maintenance, moderate throughput

Vitros 5600

Ortho Clinical Diagnostics

High throughput, comprehensive menu of tests

High cost

Architect c4000

Abbott

High throughput, comprehensive menu of tests, minimal maintenance

Requires additional modules for certain tests, high cost

Beckman Coulter AU680

Beckman Coulter

High throughput, comprehensive menu of tests, user-friendly

Requires regular maintenance, high cost

Advia 2400

Siemens

High throughput, comprehensive menu of tests, user-friendly

Requires regular maintenance, high cost

Olympus AU400e

Olympus

User-friendly, minimal maintenance

Lower throughput, limited menu of tests

Segment Highlights

Product Type Insights

Based on product, the reagents segment led the market withthe largest revenue share of 57.4% in 2023. These reagents predominantlyinclude lipids, electrolytes, specific proteins, substrates, enzymes, andothers that are imperative to receive accurate results in analytical processes.Furthermore, reagents are highly cost-effective and possess optimum precision,linearity, and sensitivity, which thereby guarantees reduced performancevariation.

The analyzers segment is expected to grow the fastest CAGRover the forecast period, owing to the wide product range and extensiveutilization in diagnosis of chronic diseases. Moreover, technologicaladvancements and high R&D expenditure have resulted in development ofadvanced analyzers which offer advantages such as better resolution, quickdiagnosis, improved point of care testing capabilities, computer assistedinterpretation, and others. The above-mentioned advantages are expected toboost the analyzers market over the forecast period.

Test Type Insights

Based on the test type, the basic metabolic panel (BMP)segment held a market with the largest revenue share of 29.56% in 2023. Thegrowth of the segment is mainly attributed to the increasing prevalence oflifestyle-related diseases, such as metabolic abnormalities and obesity. Risingawareness about the importance of point-of-care testing is a major factor contributingto the segment's growth. The related advantages of this test have resulted inhigher acceptance, thereby driving the segment growth.

The associated benefits with this test have resulted in thehigh acceptance of the same, thereby widening the segment share over the years.Moreover, BMP is increasingly being used and accepted in a wide array ofapplications, such as in newborn screening, which facilitates early detectionof congenital genetic as well as metabolic disorders. According to a researchpaper published in NCBI, it possesses the ability to detect 30 inheritedmetabolic disorders in a single dried filter paper blood spot.

End-use Insights

Based on end-use, the hospitals segment led the market in2023 with the largest revenue share of 58.42%. This is due to the large samplevolumes, frequent readmissions, and high patient volume in hospital settings.In addition, rising supportive infrastructure facilitates diagnostic processes,thus resulting in an increasing hospitalization rate. Moreover, risinggovernment initiatives to improve hospital diagnostic infrastructure to improveefficiency contribute to segmental growth.

The diagnostic laboratories segment is expected to grow atfastest CAGR over the forecast period. Automated analyzers enhance efficiency,reducing turnaround times. Increasing public awareness fosters proactive healthmonitoring, amplifying diagnostic test volumes. Governments' emphasis onaccurate diagnostics and healthcare infrastructure investments propels theadoption of advanced clinical chemistry analyzers. These factors collectivelydrive the growth of the segment during the forecasted period

Immediate Delivery Available, Get Full Access@ https://www.novaoneadvisor.com/report/checkout/7123

Major Clinical Chemistry Analyzers Market CompanyInsights

Some of the major players in the market include Abbott, F.Hoffmann-La Roche Ltd, and Thermo Fisher Scientific. Multiple strategies aretaken by the major players to enhance their market positions. Companies areinvolved in increasing their market reach by profitable agreements with otherplayers in developing countries. Product launches or approval is anotherstrategy adopted by these companies.

Developing players such as Horiba Ltd, and Shenzhen MindrayBio-Medical Electronics Co., Ltd., are taking various strategic initiativessuch as mergers & acquisitions, product launches, partnerships, andcollaborations, to improve their presence.

Some of the prominent players in theClinical chemistry analyzers market include:

Clinical Chemistry Analyzers Market RecentDevelopments

• In July 2023 , Beckman CoulterDiagnostics receives FDA clearance for the DxC 500 AU Chemistry Analyzer, anautomated system designed for small-to-medium-sized laboratories. The analyzer,featuring standardized assays, enhances clinical decision-making and patientoutcomes with proven Six Sigma performance, supporting efficiency andreliability in diagnostic testing

• In March 2023 , Thermo FisherScientific has completed the acquisition of The Binding Site Group for £2.3billion (USD 2.8 billion). The addition of The Binding Site expands ThermoFisher's Specialty Diagnostics segment, particularly in oncology testing formultiple myeloma

• In May 2023 , Siemens Healthineersintroduces the Atellica HEMA 570 and 580 Analyzers for high-volume hematologytesting. These solutions feature intuitive interfaces, multi-analyzerautomation connectivity, and rules-based testing to streamline workflows andprovide fast and reliable results for physicians and patients

Segments Covered in the Report

This report forecasts revenue growth atglobal, regional, and country levels and provides an analysis of the latestindustry trends in each of the sub-segments from 2021 to 2033. For this study,Nova one advisor, Inc. has segmented the global clinical chemistry analyzersmarket.

Product

Test

End-use

By Region

Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/7123

USA : +1804 441 9344

APAC : +61485 981 310 or +91 87933 22019

Europe : +447383 092 044

Email: [email protected]

Web: https://www.novaoneadvisor.com/

You can place an order or ask any questions, please feelfree to contact at [email protected] | +1 804 441 9344